Mar 23, 2022 7:00am EDT XORTX Files New PCT Patent to Treat and Protect Individuals Most at Risk to Severe Viral Infection
Mar 14, 2022 7:00am EDT XORTX Therapeutics Announces Submission of Clinical Trial Application to Conduct Bridging Pharmacokinetics Study
Dec 21, 2021 7:00am EST XORTX Therapeutics Announces Filing of Provision Patent for Polycystic Kidney Disease
Dec 10, 2021 7:01am EST XORTX Therapeutics Announces Publication of Mt. Sinai Study of Hospitalized COVID-19 Patients